In a patient with a Mobitz II (type 2) AV block on ECG who is asymptomatic but has nocturnal dyspnea, what is the next step in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Permanent Pacemaker Implantation is Indicated

In a patient with Mobitz type II AV block, permanent pacemaker implantation is recommended regardless of symptoms, as this is a Class I indication. 1, 2 The nocturnal dyspnea observed by the relative does not change this management—Mobitz II block itself mandates pacing due to high risk of progression to complete heart block.

Why Immediate Pacing is Required

Mobitz type II second-degree AV block is always abnormal and represents infranodal disease at the His-Purkinje system 3. Unlike Mobitz type I (Wenckebach), which can be benign and vagally mediated, Mobitz type II carries significant risk:

  • High progression rate to complete heart block (common and unpredictable) 4, 5
  • Poor prognosis without pacing, especially when associated with wide QRS 5
  • Pacemaker indication exists even in asymptomatic patients 1, 2

The 2018 ACC/AHA/HRS guidelines explicitly state: "In patients with acquired second-degree Mobitz type II atrioventricular block...permanent pacing is recommended regardless of symptoms" 1, 2.

Critical Diagnostic Considerations Before Pacing

Before proceeding to pacemaker implantation, you must:

  1. Confirm true Mobitz II block (not atypical Wenckebach or 2:1 block masquerading as Mobitz II):

    • Verify constant PR intervals before the blocked P wave
    • Ensure stable sinus rate (vagal surges can mimic Mobitz II) 6, 7
    • Rule out concealed His bundle extrasystoles (pseudo-AV block) 6, 7
  2. Exclude reversible causes:

    • Review medications (ticagrelor can cause AV block) 8
    • Check electrolytes
    • Assess for acute ischemia (though Mobitz II is rare in inferior MI) 7
  3. Perform baseline evaluation:

    • Echocardiogram to assess structural heart disease and LV function 3
    • Exercise stress test may help distinguish from 2:1 Wenckebach 3
    • Consider electrophysiology study if diagnosis uncertain 4

Addressing the Nocturnal Dyspnea

The heavy breathing at night warrants evaluation but does not alter pacing indication:

  • Screen for sleep apnea (nocturnal bradycardia should prompt this evaluation, but nocturnal bradycardia alone is NOT a pacing indication) 1, 2
  • The dyspnea may represent:
    • Sleep-disordered breathing (common, treatable with CPAP)
    • Hemodynamic consequences of intermittent AV block
    • Unrelated cardiac or pulmonary pathology

Pacing Strategy Selection

Once pacemaker indication is confirmed:

  • If LVEF 36-50% and expected ventricular pacing >40%: Use physiologic pacing (CRT or His bundle pacing) over RV pacing to prevent heart failure 1, 2
  • If LVEF >50%: Dual-chamber pacemaker (DDDR) with programming to maintain native AV conduction when possible 9
  • Optimize AV delay post-implantation to prevent diastolic mitral regurgitation from AV dyssynchrony 10

Common Pitfall to Avoid

Do not delay pacing based on the patient being "asymptomatic"—the absence of daytime symptoms does not negate the indication. Research shows that even patients with exclusively nocturnal high-grade AV block have a 21% rate of requiring pacemaker within 2.4 years due to symptom development 11. With confirmed Mobitz II, the risk is substantially higher and progression is unpredictable.

References

Guideline

indications and recommendations for pacemaker therapy.

American family physician, 2005

Research

Second-degree atrioventricular block revisited.

Herzschrittmachertherapie & Elektrophysiologie, 2012

Research

Ticagrelor Induced 2:1 Atrio-Ventricular Block After Percutaneous Coronary Intervention to Right Coronary Artery.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026

Research

Diastolic mitral regurgitation after dual chamber pacemaker.

Indian pacing and electrophysiology journal, 2024

Related Questions

Are there benign causes of Mobitz type II atrioventricular block?
In second-degree atrioventricular block, are QRS complexes dropped?
Is it safe to perform an exercise stress test in a patient with second-degree type II (Mobitz II) atrioventricular block?
In an 82-year-old woman presenting to the emergency department with shortness of breath, lightheadedness, two syncopal episodes in the past 24 hours, hypotension, bradycardia, a weak thready pulse, diaphoresis, pallor, and an electrocardiogram showing a constant PR interval with intermittent dropped QRS complexes, what is the most appropriate immediate management: intravenous dopamine, intravenous fluids, placement of a permanent pacemaker, or transcutaneous pacing?
What is the best way to describe Wenckebach (Mobitz type I second-degree atrioventricular block) to a patient in layman's terms?
Is a complete blood count (CBC) morphology the same as a peripheral blood smear?
How should I manage a patient with low cortisol who responded to cosyntropin (ACTH stimulation test), is taking daily 5 mg prednisone, and has lumbar vertebral osteoporosis?
For a woman on hormone replacement therapy, how long does the levonorgestrel intra‑uterine system (Mirena) provide uterine protection?
What is the recommended first‑line antibiotic for an otherwise healthy adult with cough, myalgia, and sore throat suggestive of streptococcal pharyngitis?
What empiric intravenous antibiotics are recommended for bacterial meningitis presenting with a bulging membrane (e.g., bulging fontanelle)?
What dose in milligrams of haloperidol long‑acting injectable (Haldol) is appropriate for a patient stable on 15 mg of oral haloperidol daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.